馬健康管理の市場規模、シェア、動向分析レポート：製品別（医薬品、ワクチン）、適応症別、活動別、流通チャネル別、地域別、セグメント別予測、2022年～2030年

馬健康管理市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界の馬健康管理市場規模は2030年までに43億7000万米ドルに達すると予測されています。同市場は2022年から2030年にかけてCAGR6.1%で拡大すると予測されています。製品の研究開発の増加、馬用診断薬の需要、業界の主要利害関係者による投資、馬の疾病の有病率の上昇などは、市場成長の主な要因の一部です。例えば、2021年9月、米国農務省は、動物栄養・健康分野に約30億米ドルを投資しました。

COVID-19のパンデミックは、特に競馬/スポーツ部門に顕著な影響を及ぼしました。馬のケアサービスへのアクセスが減少し、馬術ショーがキャンセルされる事態となっています。COVID-19の影響で、教育、訓練、競合、イベント、観光関連活動、レクリエーション活動のすべてが中止されました。競馬は世界的に影響を受け、馬小屋の需要も減少しました。EU圏内で競馬を続けているのはスウェーデンだけです。フランスの馬産業クラスターであるHippoliaが行った調査によると、回答者の68.8％が不足分の回復は不可能と考えており、すべての馬術競技が廃止されました。スポーツ馬の損失は、推計で合計3億8589万米ドルが発生しました。しかし、監禁措置の緩和や馬健康管理へのアクセス改善により、2021年に市場は回復しました。

技術的進歩、研究開発、市場プレイヤーによる馬の診断に関するイニシアティブの高まりは、市場を牽引する主要な要因となっています。例えば、米国獣医師会が発表した2022年7月の記事によると、臨床的な頭頸部合併症を持つ馬の画像化に利用される独自のヘリカルファンビームベースCTの診断性能を評価する研究が実施されました。合計120頭以上の馬が対象となり、2つの大学病院で頭頸部CTスキャンを受けた馬の診療記録が調査されました。年齢、性別、馬種、主訴、鎮静剤の使用量、手術時間、さらなる画像診断技術の使用、画像診断、臨床診断、画像に関連する問題点がすべて記録されました。このCTシステムは、馬の歯と副鼻腔の定期的な撮影において、撮影時間が短く、信頼できる有用性を持つことが証明されました。

さらに、馬の疾病が増加していることも、市場の成長を後押しする要因の一つです。例えば、ウエストナイルウイルスは、2022年9月にカリフォルニア州食品農業局によって、一過性の発熱と神経症状を示していたネバダ郡の10歳のワクチン未接種のクォーターホース種馬で陽性と確認されました。これは、2022年にカリフォルニア州で確認された8例目のウマWNVの症例でした。その他、カーン州3件、ネバダ州1件、サクラメント州1件、サンルイスオビスポ州1件、テハマ州1件、チュレア州3件の計6郡で陽性例が確認されました。今後、馬の病気に対する認識が高まり、適時のワクチン接種の需要が高まることが予想されます。

馬健康管理市場のレポートハイライト

製品別では、医薬品分野が2021年に30.0%超のシェアを占め、高い普及率と幅広い入手可能性から市場を独占している

再生医療や幹細胞治療ソリューションからなるその他の製品セグメントは、予測期間において最も急速に成長すると予測される

適応症別では、寄生虫制御が2021年に20.0%超の最大シェアを占めました。これは、内部および外部の寄生虫を制御するための効果的な寄生虫駆除剤の需要が高まっていることに起因しています

スポーツ/レース活動分野は、2021年に40.0%超の収益シェアを獲得して市場を独占し、予測期間中に最も速い速度で成長すると予測される

流通チャネル別では、2021年に動物病院とクリニックが最大のシェアを占めました。eコマースセグメントは、予測期間中に最も速いCAGRで拡大すると予測される

北米と欧州は2021年に顕著なシェアを占めました。アジア太平洋地域は、馬術レース/スポーツ分野の発展により、予測期間中に有利な成長を示すことが期待されます。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • 推定・予測のタイムライン
• 調査手法
• 情報調達
  • 購入したデータベース
  • Gvrの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
• 二次情報一覧

第2章 エグゼクティブサマリー

• 市場の見通し
• セグメントの見通し

第3章 馬健康管理市場変数の動向と範囲

• 市場系列の見通し
  • 親市場の見通し
  • アンシラリー市場の見通し
• 適応症別の浸透と成長の見通しマッピング、2021
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 業界分析- ポーターズ
  • ポーターの分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競争企業間の敵対関係
  • PESTLE分析
    • 政治的/法的情勢
    • 経済情勢
    • 社会情勢
    • テクノロジー情勢
• 推定馬頭数、2017年から2021年、主要国別
• 規制の枠組みと償還情勢
• 価格分析
• 主要地域別の推定疾患有病率分析
• 馬健康管理：COVID-19の影響
  • 現在および将来の影響分析
  • COVID-19が市場関係者に与える影響

第4章 馬健康管理市場：セグメント分析、製品別、2017年から2030年（百万米ドル）

• 製品市場シェア分析、2021年および2030年
• 馬健康管理市場：製品の変動分析
• ワクチン
• 医薬品
  • 寄生虫駆除剤
  • 抗感染症
  • 抗炎症薬と鎮痛薬
  • その他
• 薬用飼料添加物
• 診断
• ソフトウェアとサービス
• その他

第5章 馬健康管理市場：セグメント分析、適応症別、2017年から2030年（百万米ドル）

• 適応症市場シェア分析、2021年および2030年
• 馬健康管理市場：適応症の変動分析
• 筋骨格系疾患
• 寄生虫対策
• 内科
• 馬ヘルペスウイルス
• ウマ脳脊髄炎
• 馬インフルエンザ
• ウエストナイルウイルス
• 破傷風
• その他

第6章 馬健康管理市場：セグメント分析、活動別、2017年から2030年（百万米ドル）

• 活動市場シェア分析、2021年および2030年
• 馬健康管理市場：活動の変動分析
• スポーツ/レース
• レクリエーション
• その他

第7章 ウマのヘルスケア市場：セグメント分析、流通チャネル別、2017年から2030年（100万米ドル）

• 流通チャネルの市場シェア分析、2021年および2030年
• 馬健康管理市場：流通チャネル分析変動分析
• 動物病院および診療所
• eコマース
• その他

第8章 馬健康管理市場：地域市場分析、製品別、適応症、活動、および流通チャネル2017年から2030年（百万米ドル）

• 地域市場シェア分析、2021年および2030年
• 地域市場のスナップショット
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• MEA
  • 南アフリカ
  • サウジアラビア

第9章馬健康管理市場-競合情勢環境

• 企業プロファイル
  • Zoetis
    • 会社概要
    • 財務実績
    • 製品/サービスのベンチマーク
    • 戦略的イニシアチブ
  • Boehringer Ingelheim International GmbH
    • 会社概要
    • 財務実績
    • 製品/サービスのベンチマーク
    • 戦略的イニシアチブ
  • Ceva
    • 会社概要
    • 財務実績
    • 製品/サービスのベンチマーク
    • 戦略的イニシアチブ
  • SOUND
    • 会社概要
    • 財務実績
    • 製品/サービスのベンチマーク
    • 戦略的イニシアチブ
  • MERCK & CO., INC.
    • 会社概要
    • 財務実績
    • 製品/サービスのベンチマーク
    • 戦略的イニシアチブ
  • Hallmarq Veterinary Imaging
    • 会社概要
    • 財務実績
    • 製品/サービスのベンチマーク
    • 戦略的イニシアチブ
  • ESAOTE SPA
    • 会社概要
    • 財務実績
    • 製品/サービスのベンチマーク
    • 戦略的イニシアチブ
  • Vetoquinol S.A.
    • 会社概要
    • 財務実績
    • 製品/サービスのベンチマーク
    • 戦略的イニシアチブ
  • IDEXX Laboratories, Inc.
    • 会社概要
    • 財務実績
    • 製品/サービスのベンチマーク
    • 戦略的イニシアチブ
  • Dechra Pharmaceuticals PLC
    • 会社概要
    • 財務実績
    • 製品/サービスのベンチマーク
    • 戦略的イニシアチブ
• 市場参加の分類
• 企業の市況分析-ヒートマップ分析
• 相乗効果分析：主要取引と戦略的提携
• 主要企業一覧

List of Tables

• Table 1 List of secondary sources
• Table 2 List of Key Companies
• Table 3 North America Equine Healthcare market, by country, 2017 - 2030 (USD Million)
• Table 4 North America Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 5 North America Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 6 North America Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 7 North America Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 8 U.S. Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 9 U.S. Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 10 U.S. Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 11 U.S. Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 12 Canada Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 13 Canada Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 14 Canada Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 15 Canada Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 16 Europe Equine Healthcare market, by country, 2017 - 2030 (USD Million)
• Table 17 Europe Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 18 Europe Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 19 Europe Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 20 Europe Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 21 U.K. Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 22 U.K. Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 23 U.K. Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 24 U.K. Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 25 Germany Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 26 Germany Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 27 Germany Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 28 Germany Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 29 France Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 30 France Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 31 France Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 32 France Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 33 Italy Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 34 Italy Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 35 Italy Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 36 Italy Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 37 Spain Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 38 Spain Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 39 Spain Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 40 Spain Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 41 Asia Pacific Equine Healthcare market, by country, 2017 - 2030 (USD Million)
• Table 42 Asia Pacific Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 43 Asia Pacific Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 44 Asia Pacific Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 45 Asia Pacific Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 46 China Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 47 China Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 48 China Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 49 China Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 50 Japan Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 51 Japan Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 52 Japan Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 53 Japan Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 54 India Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 55 India Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 56 India Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 57 India Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 58 Australia Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 59 Australia Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 60 Australia Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 61 Australia Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 62 South Korea Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 63 South Korea Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 64 South Korea Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 65 South Korea Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 66 Latin America Equine Healthcare market, by country, 2017 - 2030 (USD Million)
• Table 67 Latin America Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 68 Latin America Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 69 Latin America Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 70 Latin America Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 71 Brazil Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 72 Brazil Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 73 Brazil Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 74 Brazil Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 75 Mexico Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 76 Mexico Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 77 Mexico Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 78 Mexico Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 79 Argentina Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 80 Argentina Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 81 Argentina Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 82 Argentina Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 83 MEA Equine Healthcare market, by country, 2017 - 2030 (USD Million)
• Table 84 MEA Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 85 MEA Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 86 MEA Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 87 MEA Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 88 South Africa Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 89 South Africa Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 90 South Africa Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 91 South Africa Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 92 Saudi Arabia Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 93 Saudi Arabia Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 94 Saudi Arabia Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 95 Saudi Arabia Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 96 Global Equine Healthcare market, by region, 2017 - 2030 (USD Million)
• Table 97 Global Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
• Table 98 Global Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
• Table 99 Global Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
• Table 100 Global Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
• Table 101 Global Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 102 North America Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 103 U.S. Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 104 Canada Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 105 Europe Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 106 U.K. Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 107 Germany Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 108 France Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 109 Italy Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 110 Spain Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 111 Asia Pacific Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 112 Japan Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 113 China Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 114 India Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 115 Australia Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 116 South Korea Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 117 Latin America Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 118 Brazil Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 119 Mexico Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 120 Argentina Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 121 MEA Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 122 South Africa Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
• Table 123 Saudi Arabia Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)

List of Figures

• Fig. 1 Market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Commodity flow analysis
• Fig. 10 Equine Healthcare Market Revenues, 2021, (USD Millions)
• Fig. 11 Parent market outlook
• Fig. 12 Ancillary market outlook
• Fig. 13 Penetration & growth prospect mapping by activity, 2021
• Fig. 14 Market trends & outlook
• Fig. 15 Market driver relevance analysis
• Fig. 16 Market restraint relevance analysis
• Fig. 17 Equine Healthcare market Product outlook: Key takeaways
• Fig. 18 Equine Healthcare market: Product movement analysis
• Fig. 19 Global Vaccines market, 2017 - 2030 (USD Million)
• Fig. 20 Global Pharmaceuticals market, 2017 - 2030 (USD Million)
• Fig. 21 Global Parasiticides market, 2017 - 2030 (USD Million)
• Fig. 22 Global Anti-infectives market, 2017 - 2030 (USD Million)
• Fig. 23 Global Anti-inflammatory & Analgesics market, 2017 - 2030 (USD Million)
• Fig. 24 Global Other Pharmaceuticals market, 2017 - 2030 (USD Million)
• Fig. 25 Global Medicinal Feed Additives market, 2017 - 2030 (USD Million)
• Fig. 26 Global Diagnostics market, 2017 - 2030 (USD Million)
• Fig. 27 Global Software & Services market, 2017 - 2030 (USD Million)
• Fig. 28 Global Others market, 2017 - 2030 (USD Million)
• Fig. 29 Equine Healthcare market Indication outlook: Key takeaways
• Fig. 30 Equine Healthcare market: Indication movement analysis
• Fig. 31 Global Musculoskeletal Disorders market, 2017 - 2030 (USD Million)
• Fig. 32 Global Parasite Control market, 2017 - 2030 (USD Million)
• Fig. 33 Global Internal Medicine market, 2017 - 2030 (USD Million)
• Fig. 34 Global Equine Herpes virus market, 2017 - 2030 (USD Million)
• Fig. 35 Global Equine Encephalomyelitis market, 2017 - 2030 (USD Million)
• Fig. 36 Global Equine Influenza market, 2017 - 2030 (USD Million)
• Fig. 37 Global West Nile Virus market, 2017 - 2030 (USD Million)
• Fig. 38 Global Tetanus market, 2017 - 2030 (USD Million)
• Fig. 39 Global Others market, 2017 - 2030 (USD Million)
• Fig. 40Equine Healthcare market Activity outlook: Key takeaways
• Fig. 41Equine Healthcare market: Activity movement analysis
• Fig. 42 Global Sports/Racing market, 2017 - 2030 (USD Million)
• Fig. 43 Global Recreation market, 2017 - 2030 (USD Million)
• Fig. 44 Global Others market, 2017 - 2030 (USD Million)
• Fig. 45 Equine Healthcare market Distribution Channel outlook: Key takeaways
• Fig. 46 Equine Healthcare market: Distribution Channel movement analysis
• Fig. 47 Global Veterinary Hospitals & Clinics market, 2017 - 2030 (USD Million)
• Fig. 48 Global E-Commerce market, 2017 - 2030 (USD Million)
• Fig. 49 Global Others market, 2017 - 2030 (USD Million)
• Fig. 50 Regional outlook, 2021 & 2030
• Fig. 51 Regional marketplace: Key takeaways
• Fig. 52 North America Equine Healthcare market by countries, 2017 - 2030 (USD Million)
• Fig. 53 U.S. Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 54 Canada Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 55 Europe Equine Healthcare market by countries, 2017 - 2030 (USD Million)
• Fig. 56 U.K. Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 57 Germany Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 58 France Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 59 Italy Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 60 Spain Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 61 Asia Pacific Equine Healthcare market by countries, 2017 - 2030 (USD Million)
• Fig. 62 Japan Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 63 China Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 64 India Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 65 Australia Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 66 South Korea Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 67 Latin America Equine Healthcare market by countries, 2017 - 2030 (USD Million)
• Fig. 68 Brazil Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 69Mexico Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 70 Argentina Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 71 MEA Equine Healthcare market by countries, 2017 - 2030 (USD Million)
• Fig. 72 South Africa Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 73 Saudi Arabia Equine Healthcare market, 2017 - 2030 (USD Million)
• Fig. 74 Market Participant Categorization
• Fig. 75 Equine Healthcare: Heat Map Analysis

Equine Healthcare Market Growth & Trends:

The global equine healthcare market size is anticipated to reach USD 4.37 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.1% from 2022 to 2030. Increasing product R&D, demand for equine diagnostics, investments by key industry stakeholders, and the rising prevalence of diseases in horses are some of the major factors contributing to the market growth. For instance, in September 2021, the U.S. Department of Agriculture invested around USD 3.0 billion in the animal nutrition and health sector.

The Covid-19 pandemic had a notable impact, particularly on the horse racing/ sports sector. It led to reduced access to equine care services and the cancelation of equine shows. Teaching, training, competitions, events, tourism-related activities, and recreational activities were all discontinued as a result of COVID-19. Horse racing was adversely impacted across the world, along with the demand for horse boarding. Only Sweden continued to hold races within the EU. According to a survey conducted by Hippolia, French Equine Industry Cluster, 68.8% of respondents believed the recovery of the shortfall is impossible, and all equine competitions have been discontinued. A total of USD 385.89 million in sport horse losses were incurred as per estimates. However, the market recovered in 2021 owing to easing lockdown measures and improved access to equine healthcare.

Growing technological advancement, R&D, and initiatives by market players in equine diagnostics are key factors driving the market. For instance, according to a July 2022 article published by the American Veterinary Medical Association, a study was carried out to assess the diagnostic performance of a unique helical fan beam-based CT utilized for imaging horses with clinical head and neck complications. A total of over 120 horses were involved, and the medical records of those who had undergone head or neck CT scans at two university hospitals were examined. Age, sex, breed, the primary complaint, the amount of sedation utilized, the length of the operation, the use of any further diagnostic imaging techniques, the imaging diagnosis, the clinical diagnosis, and any imaging-related problems were all noted. The CT system proved to have short scanning times and reliable utility for regular imaging of horses' teeth and sinuses.

Furthermore, the rising prevalence of diseases in horses is another factor propelling the market growth. West Nile Virus, for instance, was positively identified in a 10-year-old unvaccinated Quarter Horse stallion in Nevada County who was exhibiting transient fever and neurological symptoms by the California Department of Food and Agriculture in September 2022. This was the 8th confirmed case of the equine WNV in California in 2022. Other positive cases were identified in six counties: three in Kern, one in Nevada, one in Sacramento, one in San Luis Obispo, one in Tehama, and three in Tulare. This is expected to promote awareness regarding equine diseases while fueling demand for timely vaccination of horses.

Equine Healthcare Market Report Highlights:

• Based on product, the pharmaceuticals segment dominated the market with a share of over 30.0% in 2021 owing to a high uptake and wide availability of these products

• The others product segment comprising regenerative medicine and stem cell therapy solutions is projected to be the fastest growing segment in the forecast period

• Based on indication, parasite control held the largest share of over 20.0% in 2021. It is due to the growing demand for effective parasiticides for the control of internal and external parasites

• The sports/racing activity segment dominated the market with a revenue share of over 40.0% in 2021 and is anticipated to grow at the fastest rate during the forecast period

• Based on distribution channel, veterinary hospitals and clinics held the largest share in 2021. The e-commerce segment is projected to expand at the fastest CAGR during the forecast period

• North America and Europe held notable shares in 2021. The Asia Pacific is expected to witness lucrative growth in the forecast period owing to a budding equine racing/ sports sector

Table of Contents

Chapter 1 Research Methodology & Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Estimates & Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
• 1.7 List of Secondary Sources

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook

Chapter 3 Equine Healthcare Market Variables Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping by Indication, 2021
• 3.3 Market Dynamics
  • 3.3.1 Market Driver Analysis
  • 3.3.2 Market Restraint Analysis
• 3.4 Industry Analysis - Porter's
  • 3.4.1 Porter's Analysis
    • 3.4.1.1 Bargaining Power Of Suppliers
    • 3.4.1.2 Bargaining Power Of Buyers
    • 3.4.1.3 Threat Of Substitutes
    • 3.4.1.4 Threat Of New Entrants
    • 3.4.1.5 Competitive Rivalry
  • 3.4.2 Pestle Analysis
    • 3.4.2.1 Political/Legal Landscape
    • 3.5.2.2 Economic Landscape
    • 3.5.2.3 Social Landscape
    • 3.5.2.4 Technology Landscape
• 3.5 Estimated Equine Population, 2017 to 2021, by key countries
• 3.6 Regulatory Framework & Reimbursement Landscape
• 3.7 Pricing Analysis
• 3.8 Estimated Disease Prevalence Analysis, By Key Regions
• 3.9 Equine Healthcare: Covid-19 Impact
  • 3.9.1 Current And Future Impact Analysis
  • 3.9.2 Impact Of Covid-19 On Market Players

Chapter 4 Equine Healthcare Market: Segment Analysis, By Product, 2017 - 2030 (USD Million)

• 4.1 Product Market Share Analysis, 2021 & 2030
• 4.2 Equine Healthcare market: Product movement analysis
• 4.3 Vaccines
  • 4.3.1 Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 4.4 Pharmaceuticals
  • 4.4.1 Pharmaceuticals Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 4.4.2 Parasiticides
    • 4.4.2.1 Parasiticides Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 4.4.3 Anti-Infectives
    • 4.4.3.1 Anti-Infectives Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 4.4.4 Anti-Inflammatory & Analgesics
    • 4.4.4.1 Anti-Inflammatory & Analgesics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 4.4.5 Others
    • 4.4.5.1 Other Pharmaceuticals Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 4.5 Medicinal Feed Additives
  • 4.5.1 Medicinal Feed Additives Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 4.6 Diagnostics
  • 4.6.1 Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 4.7 Software & Services
  • 4.7.1software & Services Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 4.8 Others
  • 4.8.1. Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 5 Equine Healthcare Market: Segment Analysis, By Indication, 2017 - 2030 (USD Million)

• 5.1 Indication Market Share Analysis, 2021 & 2030
• 5.2 Equine Healthcare market: Indication movement analysis
• 5.3 Musculoskeletal Disorders
  • 5.3.1 Musculoskeletal Disorders Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 5.4 Parasite Control
  • 5.4.1 Parasite Control Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 5.5 Internal Medicine
  • 5.5.1 Internal Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 5.6 Equine Herpes Virus
  • 5.6.1 Equine Herpes Virus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 5.7 Equine Encephalomyelitis
  • 5.7.1 Equine Encephalomyelitis Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 5.8 Equine Influenza
  • 5.8.1 Equine Influenza Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 5.9 West Nile Virus
  • 5.9.1 West Nile Virus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 5.10 Tetanus
  • 5.10.1 Tetanus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 5.11 Others
  • 5.11.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 6 Equine Healthcare Market: Segment Analysis, By Activity, 2017 - 2030 (USD Million)

• 6.1 Activity Market Share Analysis, 2021 & 2030
• 6.2 Equine Healthcare market: Activity movement analysis
• 6.3 Sports/Racing
  • 6.3.1 Sports/Racing Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 6.4 Recreation
  • 6.4.1 Recreation Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 6.5 Others
  • 6.5.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 7 Equine Healthcare Market: Segment Analysis, By Distribution Channel, 2017 - 2030 (USD Million)

• 7.1 Distribution Channel Market Share Analysis, 2021 & 2030
• 7.2 Equine Healthcare Market: Distribution Channel Analysis Movement Analysis
• 7.3 Veterinary Hospitals & Clinics
  • 7.3.1 Veterinary Hospitals & Clinics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 7.4 E-Commerce
  • 7.4.1 E-Commerce Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 7.5 Others
  • 7.5.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 8 Equine Healthcare Market: Regional Market Analysis, By Product, Indication, Activity, and Distribution Channel 2017 - 2030 (USD Million)

• 8.1 Regional Market Share Analysis, 2021 & 2030
• 8.2 Regional Market Snapshot
• 8.3 North America
  • 8.3.1 North America Equine Healthcare Market Estimates And Forecasts By Countries, 2017 - 2030 (USD Million)
  • 8.3.2 U.S.
    • 8.3.2.1 U.S. Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • 8.3.3 Canada
    • 8.3.3.1 Canada Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
• 8.4 Europe
  • 8.4.1 Europe Equine Healthcare Market Estimates and Forecasts By Countries, 2017 - 2030 (USD MILLION)
  • 8.4.2 U.K.
    • 8.4.2.1 U.K. Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • 8.4.3 Germany
    • 8.4.3.1 Germany Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 8.4.4 France
    • 8.4.4.1 France Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 8.4.5 Italy
    • 8.4.5.1 Italy Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 8.4.6 Spain
    • 8.4.6.1 Spain Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
• 8.5 Asia Pacific
  • 8.5.1 Asia Pacific Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 8.5.2 Japan
    • 8.5.2.1 Japan Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 8.5.3 China
    • 8.5.3.1 China Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • 8.5.4 India
    • 8.5.4.1 India Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 8.5.5 Australia
    • 8.5.5.1 Australia Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • 8.5.6 South Korea
    • 8.5.6.1 South Korea Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
• 8.6 Latin America
  • 8.6.1 Latin America Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 8.6.2 Brazil
    • 8.6.2.1 Brazil Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 8.6.3 Mexico
    • 8.6.3.1 Mexico Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • 8.6.4 Argentina
    • 8.6.4.1 Argentina Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
• 8.7 MEA
  • 8.7.1 MEA Equine Healthcare Market Estimates And Forecasts By Countries, 2017 - 2030 (USD Million)
  • 8.7.2 South Africa
    • 8.7.2.1 South Africa Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 8.7.2 Saudi Arabia
    • 8.7.2.1 Saudi Arabia Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 9Equine Healthcare Market - Competitive Landscape

• 9.1 Company Profiles
  • 9.1.1 Zoetis
    • 9.1.1.1 Company Overview
    • 9.1.1.2 Financial Performance
    • 9.1.1.3 Product/Service Benchmarking
    • 9.1.1.4 Strategic Initiatives
  • 9.1.2 Boehringer Ingelheim International GmbH
    • 9.1.2.1 Company Overview
    • 9.1.2.2 Financial Performance
    • 9.1.2.3 Product/Service Benchmarking
    • 9.1.2.4 Strategic Initiatives
  • 9.1.3 Ceva
    • 9.1.3.1 Company Overview
    • 9.1.3.2 Financial Performance
    • 9.1.3.3 Product/Service Benchmarking
    • 9.1.3.4 Strategic Initiatives
  • 9.1.4 SOUND
    • 9.1.4.1 Company Overview
    • 9.1.4.2 Financial Performance
    • 9.1.4.3 Product/Service Benchmarking
    • 9.1.4.4 Strategic Initiatives
  • 9.1.5 MERCK & CO., INC.
    • 9.1.5.1 Company Overview
    • 9.1.5.2 Financial Performance
    • 9.1.5.3 Product/Service Benchmarking
    • 9.1.5.4 Strategic Initiatives
  • 9.1.6 Hallmarq Veterinary Imaging
    • 9.1.6.1 Company Overview
    • 9.1.6.2 Financial Performance
    • 9.1.6.3 Product/Service Benchmarking
    • 9.1.6.4 Strategic Initiatives
  • 9.1.7 ESAOTE SPA
    • 9.1.7.1 Company Overview
    • 9.1.7.2 Financial Performance
    • 9.1.7.3 Product/Service Benchmarking
    • 9.1.7.4 Strategic Initiatives
  • 9.1.8 Vetoquinol S.A.
    • 9.1.8.1 Company Overview
    • 9.1.8.2 Financial Performance
    • 9.1.8.3 Product/Service Benchmarking
    • 9.1.8.4 Strategic Initiatives
  • 9.1.9 IDEXX Laboratories, Inc.
    • 9.1.9.1 Company Overview
    • 9.1.9.2 Financial Performance
    • 9.1.9.3 Product/Service Benchmarking
    • 9.1.9.4 Strategic Initiatives
  • 9.1.10 Dechra Pharmaceuticals PLC
    • 9.1.10.1 Company Overview
    • 9.1.10.2 Financial Performance
    • 9.1.10.3 Product/Service Benchmarking
    • 9.1.10.4 Strategic Initiatives
• 9.2 Market Participation Categorization
• 9.3 Company Market Position Analysis - Heat Map Analysis
• 9.4 Synergy Analysis: Major Deals & Strategic Alliances
• 9.5 List of Key Companies